Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival - PubMed (original) (raw)
Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival
Nirmitha I Herath et al. BMC Cancer. 2006.
Abstract
Background: Increased expression of Eph receptor tyrosine kinases and their ephrin ligands has been implicated in tumor progression in a number of malignancies. This report describes aberrant expression of these genes in ovarian cancer, the commonest cause of death amongst gynaecological malignancies.
Methods: Eph and ephrin expression was determined using quantitative real time RT-PCR. Correlation of gene expression was measured using Spearman's rho statistic. Survival was analysed using log-rank analysis and (was visualised by) Kaplan-Meier survival curves.
Results: Greater than 10 fold over-expression of EphA1 and a more modest over-expression of EphA2 were observed in partially overlapping subsets of tumors. Over-expression of EphA1 strongly correlated (r = 0.801; p < 0.01) with the high affinity ligand ephrin A1. A similar trend was observed between EphA2 and ephrin A1 (r = 0.387; p = 0.06). A striking correlation of both ephrin A1 and ephrin A5 expression with poor survival (r = -0.470; p = 0.02 and r = -0.562; p < 0.01) was observed. Intriguingly, there was no correlation between survival and other clinical parameters or Eph expression.
Conclusion: These data imply that increased levels of ephrins A1 and A5 in the presence of high expression of Ephs A1 and A2 lead to a more aggressive tumor phenotype. The known functions of Eph/ephrin signalling in cell de-adhesion and movement may explain the observed correlation of ephrin expression with poor prognosis.
Figures
Figure 1
Transcript number of Eph and ephrin genes in non-malignant (N) and tumorigenic (T) tissues, relative to 108 copies of 18S rRNA shown on a log scale. Whiskers show the 10th–90th percentile range while the shaded areas show the 25th–75th percentile range. The thin and heavy horizontal lines represent the median and the mean respectively.
Figure 2
Plots showing association between high and low levels of ephrin A1 or ephrin A5, in conjunction, with survival.
Similar articles
- The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors.
Wu Y, Du Z, Mou J, Qiu X, Chen J, Cai S, Ren D, Xiao F, Zhou G, Yuan C. Wu Y, et al. Curr Med Chem. 2023;30(20):2340-2353. doi: 10.2174/0929867329666220820125638. Curr Med Chem. 2023. PMID: 35996244 Review. - The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas.
Han L, Dong Z, Qiao Y, Kristensen GB, Holm R, Nesland JM, Suo Z. Han L, et al. Gynecol Oncol. 2005 Nov;99(2):278-86. doi: 10.1016/j.ygyno.2005.06.036. Epub 2005 Aug 2. Gynecol Oncol. 2005. PMID: 16061279 - Experimental hypoxia does not influence gene expression and protein synthesis of Eph receptors and ephrin ligands in human melanoma cells in vitro.
Reissenweber B, Mosch B, Pietzsch J. Reissenweber B, et al. Melanoma Res. 2013 Apr;23(2):85-95. doi: 10.1097/CMR.0b013e32835e58f3. Melanoma Res. 2013. PMID: 23358429 - Eph-ephrin A system regulates human choriocarcinoma-derived JEG-3 cell invasion.
Fujiwara H, Nishioka Y, Matsumoto H, Suginami K, Horie A, Tani H, Matsumura N, Baba T, Sato Y, Araki Y, Konishi I. Fujiwara H, et al. Int J Gynecol Cancer. 2013 Mar;23(3):576-82. doi: 10.1097/IGC.0b013e3182849e36. Int J Gynecol Cancer. 2013. PMID: 23429488 - Roles of EphA1/A2 and ephrin-A1 in cancer.
Ieguchi K, Maru Y. Ieguchi K, et al. Cancer Sci. 2019 Mar;110(3):841-848. doi: 10.1111/cas.13942. Epub 2019 Feb 15. Cancer Sci. 2019. PMID: 30657619 Free PMC article. Review.
Cited by
- Integrated analysis of spatial transcriptomics and CT phenotypes for unveiling the novel molecular characteristics of recurrent and non-recurrent high-grade serous ovarian cancer.
Ju HY, Youn SY, Kang J, Whang MY, Choi YJ, Han MR. Ju HY, et al. Biomark Res. 2024 Aug 12;12(1):80. doi: 10.1186/s40364-024-00632-7. Biomark Res. 2024. PMID: 39135097 Free PMC article. - Identification of potent pan-ephrin receptor kinase inhibitors using DNA-encoded chemistry technology.
Madasu C, Liao Z, Parks SE, Sharma KL, Bohren KM, Ye Q, Li F, Palaniappan M, Tan Z, Yuan F, Creighton CJ, Tang S, Masand RP, Guan X, Young DW, Monsivais D, Matzuk MM. Madasu C, et al. Proc Natl Acad Sci U S A. 2024 May 7;121(19):e2322934121. doi: 10.1073/pnas.2322934121. Epub 2024 May 3. Proc Natl Acad Sci U S A. 2024. PMID: 38701119 - Lymphatic vasculature in ovarian cancer.
Pal S, Bhowmick S, Sharma A, Sierra-Fonseca JA, Mondal S, Afolabi F, Roy D. Pal S, et al. Biochim Biophys Acta Rev Cancer. 2023 Sep;1878(5):188950. doi: 10.1016/j.bbcan.2023.188950. Epub 2023 Jul 5. Biochim Biophys Acta Rev Cancer. 2023. PMID: 37419192 Free PMC article. Review. - Anti-angiogenic therapy in ovarian cancer: Current understandings and prospects of precision medicine.
Mei C, Gong W, Wang X, Lv Y, Zhang Y, Wu S, Zhu C. Mei C, et al. Front Pharmacol. 2023 Mar 7;14:1147717. doi: 10.3389/fphar.2023.1147717. eCollection 2023. Front Pharmacol. 2023. PMID: 36959862 Free PMC article. Review. - Systematic Investigation of the Diagnostic and Prognostic Impact of LINC01087 in Human Cancers.
De Palma FDE, Carbonnier V, Salvatore F, Kroemer G, Pol JG, Maiuri MC. De Palma FDE, et al. Cancers (Basel). 2022 Dec 3;14(23):5980. doi: 10.3390/cancers14235980. Cancers (Basel). 2022. PMID: 36497462 Free PMC article.
References
- Boyd AW, Lackmann M. Signals from Eph and ephrin proteins: a developmental tool kit. Sci STKE. 2001;RE20 - PubMed
- Gale NW, Holland SJ, Valenzuela DM, Flenniken A, Pan L, Ryan TE, Henkemeyer M, Strebhardt K, Hirai H, Wilkinson DJ, Pawson T, Davis S, Yancoupoulos GD. Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalised during embryogenesis. Neuron. 1996;17:9–19. doi: 10.1016/S0896-6273(00)80276-7. - DOI - PubMed
- Coulthard MG, Duffy S, Down M, Evans B, Power M, Smith F, Stylianou C, Kleikamp S, Oates A, Lackmann M, Burns GF, Boyd AW. The role of the Eph-ephrin signalling system in the regulation of developmental patterning. Int J Dev Biol. 2002;46:375–384. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous